Keith Regnante
Director of Finance/CFO presso KEROS THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Keith C.
Regnante is currently the Chief Financial Officer at Keros Therapeutics, Inc. He previously worked as the Senior Director-Corporate Finance at Biogen, Inc. from 1999 to 2013, Head-Research & Development Finance at ARIAD Pharmaceuticals, Inc. from 2013 to 2014, Vice President-Finance at Shire Pharmaceuticals, Inc. from 2014 to 2016, and Chief Financial & Accounting Officer at Wave Life Sciences Ltd.
from 2016 to 2020.
He received his undergraduate degree from Tufts University and his MBA from MIT Sloan School of Management.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
KEROS THERAPEUTICS, INC.
-.--% | 13/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Keith Regnante
Società | Posizione | Inizio |
---|---|---|
KEROS THERAPEUTICS, INC. | Director of Finance/CFO | 01/02/2020 |
Precedenti posizioni note di Keith Regnante
Società | Posizione | Fine |
---|---|---|
WAVE LIFE SCIENCES LTD. | Director of Finance/CFO | 09/01/2020 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01/08/2016 |
ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2014 |
BIOGEN INC. | Public Communications Contact | 01/08/2013 |
Formazione di Keith Regnante
Tufts University | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BIOGEN INC. | Health Technology |
WAVE LIFE SCIENCES LTD. | Health Technology |
KEROS THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
- Borsa valori
- Insiders
- Keith Regnante